A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
Active, not recruiting · NCT06532331 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 1 | 2026-10-06 | NCT06532331 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ono Pharmaceutical Co., Ltd. | 47 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aichi Cancer Center | Nagoya | Japan | 6 |
| Juntendo University Hpspital | Bunkyo-ku | Japan | 1 |
| Kanagawa Cancer Center | Yokohama | Japan | 10 |
| Kanazawa University Hospital | Kanazawa | Japan | 5 |
| National Cancer Center Hospital East | Kashiwa-shi | Japan | 11 |
| Osaka International Cancer Institute | Osaka | Japan | 10 |
| Seirei Hamamatsu General Hospital | Hamamatsu | Japan | 4 |
| The Cancer Institute Hospital Of JFCR | Koto-ku | Japan | 11 |
| The University of Tokyo Hospital | Bunkyo-ku | Japan | 2 |